Elevated plasma levels of TIMP-3 are associated with a higher risk of acute respiratory distress syndrome and death following severe isolated traumatic brain injury.

Autor: Hendrickson CM; Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of California San Francisco, San Francisco, California, USA., Gibb SL; Department of Laboratory Medicine, University of California San Francisco, San Francisco, California, USA.; Blood Systems Research Institute, San Francisco, California, USA., Miyazawa BY; Department of Laboratory Medicine, University of California San Francisco, San Francisco, California, USA.; Blood Systems Research Institute, San Francisco, California, USA.; Department of Surgery, University of California San Francisco, Zuckerberg San Francisco General Hospital, San Francisco, California, USA., Keating SM; Blood Systems Research Institute, San Francisco, California, USA., Ross E; Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of California San Francisco, San Francisco, California, USA., Conroy AS; Department of Surgery, University of California San Francisco, Zuckerberg San Francisco General Hospital, San Francisco, California, USA., Calfee CS; Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of California San Francisco, San Francisco, California, USA., Pati S; Department of Laboratory Medicine, University of California San Francisco, San Francisco, California, USA.; Blood Systems Research Institute, San Francisco, California, USA., Cohen MJ; Department of Surgery, University of California San Francisco, Zuckerberg San Francisco General Hospital, San Francisco, California, USA.; Department of Surgery, University of Colorado, Denver, Colorado, USA.
Jazyk: angličtina
Zdroj: Trauma surgery & acute care open [Trauma Surg Acute Care Open] 2018 Jun 27; Vol. 3 (1), pp. e000171. Date of Electronic Publication: 2018 Jun 27 (Print Publication: 2018).
DOI: 10.1136/tsaco-2018-000171
Abstrakt: Background: Complications after injury, such as acute respiratory distress syndrome (ARDS), are common after traumatic brain injury (TBI) and associated with poor clinical outcomes. The mechanisms driving non-neurologic organ dysfunction after TBI are not well understood. Tissue inhibitor of matrix metalloproteinase-3 (TIMP-3) is a regulator of matrix metalloproteinase activity, inflammation, and vascular permeability, and hence has plausibility as a biomarker for the systemic response to TBI.
Methods: In a retrospective study of 182 patients with severe isolated TBI, we measured TIMP-3 in plasma obtained on emergency department arrival. We used non-parametric tests and logistic regression analyses to test the association of TIMP-3 with the incidence of ARDS within 8 days of admission and in-hospital mortality.
Results: TIMP-3 was significantly higher among subjects who developed ARDS compared with those who did not (median 2810 pg/mL vs. 2260 pg/mL, p=0.008), and significantly higher among subjects who died than among those who survived to discharge (median 2960 pg/mL vs. 2080 pg/mL, p<0.001). In an unadjusted logistic regression model, for each SD increase in plasma TIMP-3, the odds of ARDS increased significantly, OR 1.5 (95% CI 1.1 to 2.1). This association was only attenuated in multivariate models, OR 1.4 (95% CI 1.0 to 2.0). In an unadjusted logistic regression model, for each SD increase in plasma TIMP-3, the odds of death increased significantly, OR 1.7 (95% CI 1.2 to 2.3). The magnitude of this association was greater in a multivariate model adjusted for markers of injury severity, OR 1.9 (95% CI 1.2 to 2.8).
Discussion: TIMP-3 may play an important role in the biology of the systemic response to brain injury in humans. Along with clinical and demographic data, early measurements of plasma biomarkers such as TIMP-3 may help identify patients at higher risk of ARDS and death after severe isolated TBI.
Level of Evidence: III.
Competing Interests: Competing interests: None declared.
Databáze: MEDLINE